UK watchdog blocks AstraZeneca, Daiichi’s breast cancer drug
Daiichi Sankyo and AstraZeneca’s breast cancer treatment ran into opposition from the UK’s healthcare spending watchdog, which wants Enhertu drug to be offered.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Daiichi Sankyo and AstraZeneca’s breast cancer treatment ran into opposition from the UK’s healthcare spending watchdog, which wants Enhertu drug to be offered.
HQ Team December 6, 2023: Junior hospital doctors, who make up about half of the National Health Service (NHS) medical workforce in England,.
HQ Team November 24, 2023: One in five children and young people in England aged between eight and 25 had a probable mental.
HQ Team June 3, 2023: A blood test accurately predicted two out of three cancers and their origins during a National Health Service.